Latest News
Nebius is one of the fastest-growing businesses in AI infrastructure, but it's pricey.
Via The Motley Fool · August 17, 2026
The energy giant's weakest link isn't a red flag.
Via The Motley Fool · August 17, 2026
The stock has risen by more than 85% in the past 12 months.
Via The Motley Fool · August 17, 2026
Birkenstock topped Q3 revenue estimates and raised FY2026 guidance, but shares fell after L Catterton's $1 billion secondary offering, partly offset by a $500 million share buyback.
Via MarketBeat · August 17, 2026
Oklo is poised to become one of nuclear energy's biggest winners.
Via The Motley Fool · August 17, 2026
Revenue guidance slashed as commercial execution stumbles and academic spending weakens.
Via The Motley Fool · August 17, 2026
Coppetti's open-market purchase at an average of $30.67 per share came as the stock traded near 12-month lows, signaling insider confidence in the Zurich-based footwear maker's valuation.
Via The Motley Fool · August 17, 2026
It's hard to go wrong with the Vanguard S&P 500 ETF.
Via The Motley Fool · August 17, 2026
These energy companies are moving forward with an important new pipeline system.
Via The Motley Fool · August 17, 2026
German cannabis exports surged 74% year-over-year, driving net income to $7.2 million.
Via The Motley Fool · August 17, 2026
Management reaffirmed fiscal 2027 guidance despite first-quarter sales headwinds.
Via The Motley Fool · August 17, 2026
The microreactor maker plans to deploy new reactors at a "world record" speed.
Via The Motley Fool · August 17, 2026
Shares of Netflix are still down 30% over the past 12 months, but there are plenty of reasons for investors to be optimistic.
Via The Motley Fool · August 17, 2026
Memory chipmakers ripped higher Monday after Washington pushed Apple away from Chinese DRAM suppliers, while the 30-year yield hit a fresh 19-year peak.
Via Benzinga · August 17, 2026
Gemini stock is now down more than 60% in 2026.
Via The Motley Fool · August 17, 2026
Eyepoint Pharmaceuticals (NASDAQ:EYPT) reported topline results from LUGANO, the first of two Phase III trials evaluating DURAVYU, a vorolanib intravitreal insert, in patients with wet age-related macular degeneration, or wet AMD. The study did not meet its primary non-inferiority endpoint in the fu
Via MarketBeat · August 17, 2026
Erdene Resource Development (TSE:ERD) reported higher second-quarter gold production and lower unit costs as the Bayan Khundii Gold Mine in southwestern Mongolia continued its ramp-up toward steadier operations.
The Bayan Khundii mine, held through the 50/50 Erdene Mongol joint venture with Mongoli
Via MarketBeat · August 17, 2026
Investor Gary Black sees the odds of a SpaceX bid for Tesla as high. Here's his cautions on valuation and impatient investors.
Via Benzinga · August 17, 2026
D-Wave Quantum shares are recovering after a mixed Q2 2026 report, as investors weigh a small Canadian grant against the need for repeatable revenue, new customers, and progress toward profitability.
Via MarketBeat · August 17, 2026
Collection rate headwinds and delayed cost cuts weighed on Q2 results.
Via The Motley Fool · August 17, 2026
Data protection gains offset by pricing pressure in endpoint markets.
Via The Motley Fool · August 17, 2026
Gaming revenue beat guidance on expansion packs, but Q3 outlook signals sharp slowdown ahead.
Via The Motley Fool · August 17, 2026
Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.
Via The Motley Fool · August 17, 2026
The fundamentals remain remarkably strong.
Via The Motley Fool · August 17, 2026
Uber Eats teams up with Zipline for autonomous drone delivery. Read the full analysis on $UBER stock, technical trends, and price targets.
Via Benzinga · August 17, 2026